Shining with the Light of Wisdom, Passing on the Torch of Scholarship — The Joint Master’s Thesis Defense Ceremony between Qirui Pharmaceutical and China Pharmaceutical University Concludes Successfully
Category: News and Information
Release Date: 2024-06-07
Summary:
During this season of wisdom and enthusiasm marking graduation, the thesis defense for master’s graduates jointly trained by Qirui Pharmaceutical and China Pharmaceutical University concluded successfully at Qirui Pharmaceutical. This event not only provided a comprehensive review of the students’ academic achievements but also served as an intellectual exchange and a forum for the transmission of knowledge. Attending the ceremony were: Professor Lu Shan from Hubei University of Chinese Medicine, who chaired the defense; Cheng Die, Process Director at Ruisheng Pharmaceutical, and Liu Chao from the Biologics Platform, who served as members of the defense committee; Yu Lin, Deputy General Manager of Qirui Pharmaceutical and the corporate mentor for the joint graduate program; Qi Zhengchun, Head of the Pilot-Scale Research Platform in the department where the jointly trained graduate students are based; the two jointly trained graduate students, Sun Meng and Yu Chenyang; and Chen Tianpei from the Human Resources Department, who acted as the defense secretary.
I. The Blossom of Academia, Brilliantly in Full Bloom
After months of meticulous preparation, our students have achieved impressive research outcomes at our company. Through in-depth investigation and rigorous argumentation, they presented their latest discoveries and innovative insights in their respective fields on the defense stage. These papers not only demonstrate the depth and breadth of undergraduate academic research but also highlight the wisdom and potential of young scholars.

II. A Clash of Wisdom, a Collision of Ideas
At the defense session, students displayed confident and vigorous demeanor as they presented their research findings and calmly addressed questions from the reviewing faculty. Through in-depth exchanges and lively discussions, not only was students’ academic enthusiasm further ignited, but also the advancement of scholarly research was significantly promoted.

III. Passing on the Flame, Endless Vitality
This defense not only showcases academic achievements but also serves as a vital conduit for the transmission of scholarly knowledge. The reviewing faculty provided meticulous guidance and incisive feedback, thereby illuminating the path forward for our students. Their scholarly ethos, research methodologies, and innovative thinking will continue to inspire us to press ahead on our academic journey and to contribute meaningfully to the future development of scholarship.
(Yu Lin, Deputy General Manager of Qirui Pharmaceutical, and Yu Chenyang, a jointly supervised graduate student) 
(Yu Lin, Deputy General Manager of Qirui Pharmaceutical, and Sun Meng, a jointly supervised graduate student)
IV. Looking Ahead and Pressing On with Determination
With the successful conclusion of the defense session, our students are now poised to embark on a new chapter in their academic and professional journeys. We are confident that this experience will serve as a valuable asset on their path of development, inspiring them to pursue excellence and strive for greater heights in their scholarly pursuits. We also look forward to seeing more students engage in academic research in the pharmaceutical field, exploring the profound insights and innovative solutions it offers, and collectively advancing the ongoing development of the life and health sector.
(From left to right: Dissertation Defense Committee Member Cheng Die, Defense Chair Lu Shan, Jointly Supervised Graduate Student Yu Chenyang, Dissertation Defense Committee Member Liu Chao, and Defense Secretary Chen Tianpei) 
(From left to right: Dissertation Defense Committee Member Cheng Die, Defense Chair Lu Shan, Jointly Trained Graduate Student, Dissertation Defense Committee Member Liu Chao, and Defense Secretary Chen Tianpei)
Correspondent | Chen Tianpei
Keywords: Shining with the Light of Wisdom, Passing on the Torch of Scholarship — The Joint Master’s Thesis Defense Ceremony between Qirui Pharmaceutical and China Pharmaceutical University Concludes Successfully
Related News Centers
Academic Column
Development History
-
2019
Release time:2023-01-05
-
2018
Release time:2023-01-05
-
2017
Release time:2023-01-05
-
2014
Release time:2023-01-05
-
2013
Release time:2023-01-05
-
2012
Release time:2023-01-05
-
2011
Release time:2023-01-05
-
2010
Release time:2023-01-05
-
2009
Release time:2023-01-05
-
2008
Release time:2023-01-05
-
2007
Release time:2023-01-05
-
2006
Release time:2023-01-05
-
2005
Release time:2023-01-05
-
2004
Release time:2022-12-30
-
2003
Release time:2022-12-30
Branch office
News and Information
-
Qirui Group’s First Innovative Drug, MY008211A Tablets (Lanocapam Hydrochloride Tablets), Successfully Achieves the Primary Efficacy Endpoint in Phase III Clinical Trials
Release time:2026-02-25
-
Qirui Group’s First Innovative Drug Passes Both National Key Inspections on the First Attempt
Release time:2026-01-27
-
Three Employees of Qirui Pharmaceutical Awarded Jiangxia District’s Tangxun Lake Talent Recognition!
Release time:2026-01-15
-
“A ‘Start’ That Stands Out, Bringing in Talented Young Professionals — Qirui Group’s 2026 Campus Recruitment Concludes Successfully”
Release time:2025-12-31
-
Qirui Pharmaceutical’s Ganyining® Ademetionine Disulfonate for Injection Wins Bid in the 11th National Centralized Procurement Round
Release time:2025-11-11
-
Qirui Group Makes Its Debut at the 17th Bio-Industry Conference
Release time:2025-09-08
-
Empowering Your Journey, Illuminating the Path Ahead—Qirui Group’s 2025 New Graduate Onboarding Program Concludes Successfully
Release time:2025-07-23
-
Internationally Accredited! Qirui Technology Earns ACCA Recognized Employer Status
Release time:2025-07-08
-
Safeguarding the Source of Life and Fortifying the Quality Defense Line for Pharmaceutical Water — Professional Training on Purified Water Systems at Qirui Pharmaceutical
Release time:2025-06-05
-
Wuhan Qirui Technology Development Co., Ltd. Donates RMB 100 Million to Huazhong University of Science and Technology
Release time:2025-03-17
-
People-Oriented, Win-Win Future | Qirui Pharmaceutical Honored as “2024 China’s Top Employer”
Release time:2025-02-18
-
Empowering Party Building to Unite New Forces, Achieve Synergy, and Expand “Health”
Release time:2024-07-10
-
Qirui Group Makes Its Debut at CPHI China 2024
Release time:2024-06-28
-
Enhancing Competence Through Competition and Pursuing Development Through Quality: Qirui Pharmaceutical Successfully Holds Its 2024 Annual Quality Knowledge Competition
Release time:2024-06-28
-
Shining with the Light of Wisdom, Passing on the Torch of Scholarship — The Joint Master’s Thesis Defense Ceremony between Qirui Pharmaceutical and China Pharmaceutical University Concludes Successfully
Release time:2024-06-07
-
Academic Gala | The 8th International Forum on Drug-Induced Liver Injury Concludes Successfully; Ornithine Aspartate Recommended in the “Chinese Guidelines for Primary Care Diagnosis and Management of Drug-Induced Liver Injury (2024)”
Release time:2024-05-31
-
Qirui Pharmaceutical Awarded the “Wuhan May Day Labor Medal”
Release time:2024-05-13
-
Qirui Pharmaceutical Selected for Inclusion in the 2023 Jiangxia District List of Proposed Projects for District-Level Technology Transfer and Key R&D Initiatives
Release time:2024-04-12
-
“Made in Wuhan” Generic Drugs Added to the 2020 National Reimbursement Drug List
Release time:2021-03-05
-
Congratulatory Letter to Shandong Ruiyin Bioengineering Co., Ltd.
Release time:2021-02-01
-
Douyin Live Stream Coverage | Qirui’s 2020 Annual Work Summary and Awards Ceremony Held Successfully!
Release time:2021-01-28
-
First Public Notice of the Environmental Impact Assessment for the Demonstration Project on the Transformation and Construction of a Multi-Functional, Intelligent, Safe, Green, and High-End Active Pharmaceutical Ingredient Production Platform and Pilot-Scale Service Platform at Wuhan Zhongyou Pharmaceutical Co., Ltd.
Release time:2020-06-28
-
Decision on Commending the 2020 Pioneers in Epidemic Prevention Responsibility and Model Workers in Resuming Work and Production
Release time:2020-05-11
-
Notice of the Renewal of the Employee Care and Corporate Culture Development Committee
Release time:2020-04-27
Sunshine Avenue, Sunshine Third Road, Miaoshan Subdistrict, Economic Development Zone, Jiangxia District, Wuhan, Hubei Province
QR code
Copyright © Wuhan Qirui Pharmaceutical Co., Ltd. |Privacy Policy
Powered by www.300.cn
This website supports IPv6.